Circulating tumor DNA as a novel prognostic indicator - Nature Medicine

  • 📰 NatureMedicine
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 53%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

In our latest News and VIews, Ana Vivancos and TaberneroJosep discuss a potential new use for ctDNA as a prognostic indicator in NSCLC VHIO vallhebron

A.V. reports personal financial interest in the form of scientific consultancy roles for Bayer, Bristol-Myers Squibb, Guardant Health, Incyte, Merck Serono, Novartis and Roche. J.T. reports personal financial interest in the form of scientific consultancy roles for Array Biopharma, AstraZeneca, Bayer, Boehringer Ingelheim, Chugai, Daiichi Sankyo, F.

Hoffmann-La Roche Ltd, Genentech Inc, HalioDX SAS, Hutchison MediPharma International, Ikena Oncology, Inspirna Inc, IQVIA, Lilly, Menarini, Merck Serono, Merus, MSD, Mirati, Neophore, Novartis, Ona Therapeutics, Orion Biotechnology, Peptomyc, Pfizer, Pierre Fabre, Samsung Bioepis, Sanofi, Scandion Oncology, Scorpion Therapeutics, Seattle Genetics, Servier, Sotio Biotech, Taiho, Tessa Therapeutics and TheraMyc, as well as stock holdings in Oniria Therapeutics and also educational collaboration...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 451. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer - Nature MedicineIn a prospective cohort of 1,127 patients with non-small cell lung cancer and ctDNA-guided therapy, ctDNA detection was associated with shorter survival, independently of clinicopathologic features. NSCLC LungCancer LCAM22 MSKCancerCenter MSKCancerCenter MSK is the worst place on earth! My beautiful 37 year old daughter died from horrible doctors she had ! Septic shock right in hospital doctors did nothing to stop it! MSKCancerCenter It’s lung cancer awareness month and I have lung cancer now I’m wheezing short of breath and you can’t get me in for a ct scan till end of November? That’s a disgrace. Been with you three years I deserve better
Source: NatureMedicine - 🏆 451. / 53 Read more »

Acute and postacute sequelae associated with SARS-CoV-2 reinfection - Nature MedicineA new analysis using US Department of Veterans Affairs databases showed that reinfection is associated with increased risk of all-cause mortality, hospitalization and a wide range of long COVID complications in individuals who have had SARS-CoV-2 compared to those with no reinfection. high bias The drug BC007 developed by small german lab berlincures cured 5 LongCovid Pts. over 1 year ago! Since then nothing has happened. The German Government needs to provide support for clinical trials & drug approval ASAP, but they choose not to! Unethical! zalaly DeptVetAffairs It's interesting that it shows a slightly larger risk increase for repeated covid infections for people with repeated vaccination. It makes me wonder if the covid vaccination introduces a small bit of risk overall mortality risk that isn't well defined.
Source: NatureMedicine - 🏆 451. / 53 Read more »

Spatial genomics maps the structure, nature and evolution of cancer clones - NatureA workflow centred around base-specific in situ sequencing generates detailed maps of, and can phenotypically characterize, the unique set of subclones of cancers. Researchers develop a new method to map the spatial evolution of cancers Portfolio emblebi sangerinstitute cancer oncology genetics evolution
Source: Nature - 🏆 64. / 68 Read more »